tag:blogger.com,1999:blog-754894216207950592.post3540575018159350968..comments2024-03-20T15:55:23.392-07:00Comments on NoNameStocks: HEMA is still cheapDan Schumhttp://www.blogger.com/profile/05728696891530868697noreply@blogger.comBlogger25125tag:blogger.com,1999:blog-754894216207950592.post-4707167683284232612018-04-22T07:12:57.783-07:002018-04-22T07:12:57.783-07:00I don’t think I’d buy at this price and taxes don’...I don’t think I’d buy at this price and taxes don’t figure into my thinking. Dan Schumhttps://www.blogger.com/profile/05728696891530868697noreply@blogger.comtag:blogger.com,1999:blog-754894216207950592.post-29417444677514714232018-04-22T07:03:24.350-07:002018-04-22T07:03:24.350-07:00Would you consider buying at this price or are you...Would you consider buying at this price or are you holding for tax considerations?shlomi ardanhttps://www.blogger.com/profile/07874789224772122260noreply@blogger.comtag:blogger.com,1999:blog-754894216207950592.post-49226345862837933432018-03-17T05:30:33.859-07:002018-03-17T05:30:33.859-07:00I imagine the donors get paid. I’ve never askedI imagine the donors get paid. I’ve never askedDan Schumhttps://www.blogger.com/profile/05728696891530868697noreply@blogger.comtag:blogger.com,1999:blog-754894216207950592.post-18362691905113217552018-03-17T00:01:30.385-07:002018-03-17T00:01:30.385-07:00Question. Isn’t there a problem making so much mon...Question. Isn’t there a problem making so much money out of Donors? Usually donations are for non profit orgs. Other than that all looks great and iotahttps://www.blogger.com/profile/04353887412722440077noreply@blogger.comtag:blogger.com,1999:blog-754894216207950592.post-78786373247781163612018-01-09T22:24:02.716-08:002018-01-09T22:24:02.716-08:00I must’ve missed that. Could you email me a copy? ...I must’ve missed that. Could you email me a copy? Or else I could email the companyDan Schumhttps://www.blogger.com/profile/05728696891530868697noreply@blogger.comtag:blogger.com,1999:blog-754894216207950592.post-388172828245933002018-01-09T21:46:37.532-08:002018-01-09T21:46:37.532-08:00Happy holidays greeting message sent to shareholde...Happy holidays greeting message sent to shareholder dated 20Dec17 with "750 new donors" ebing the only part of the text highlighted in italic... must be significant otherwise why bother?Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-754894216207950592.post-26785235016637307212018-01-07T11:00:27.419-08:002018-01-07T11:00:27.419-08:00Which press release are you referring to?
I don’t...Which press release are you referring to?<br /><br />I don’t know how many donors they have. Dan Schumhttps://www.blogger.com/profile/05728696891530868697noreply@blogger.comtag:blogger.com,1999:blog-754894216207950592.post-38657082842591462942018-01-07T02:59:33.869-08:002018-01-07T02:59:33.869-08:00Does anyone know hoe many donors are currently enr...Does anyone know hoe many donors are currently enrolled? I.e. how good is the increase of 750 donors in the last press release?Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-754894216207950592.post-29647797758575705082017-03-16T23:01:35.621-07:002017-03-16T23:01:35.621-07:00Regarding valuation you have to consider the $800K...Regarding valuation you have to consider the $800K was really done in 6 months. In the first half of 2016, they were negative 80K. So w/ the growth the 12 month run rate is around $1.6M+ of net income. <br /><br />plus these guys are in a market where there is huge operating leverage. so increamental revenue will have big impact on bottom line. plus NOLs to protect the income. so i think any valuation has to consider all this.<br /><br />as for revenue, you have to realize the OneBlood deal is huge for the company. and that hasn't even come in on the results. so revenue will increase and grow. the 50% growth last year was without OneBlood, the israeli distribution, and the international distribution via OneBlood. so i wouldn't be surprised if they do 50%+ in rev growth in 2017. pakiyahttps://www.blogger.com/profile/17516457333986786704noreply@blogger.comtag:blogger.com,1999:blog-754894216207950592.post-16851380335706180612017-03-15T15:21:42.565-07:002017-03-15T15:21:42.565-07:00from last year's shareholder letter in the ann...from last year's shareholder letter in the annual report, "We estimate the market for HemaCare products and services is at least<br />$500 million, and industry reports suggest this market will triple over the next 10 years, as<br />additional biopharma and biotechnology companies: (1) enter the immunotherapy, cell<br />therapy, and regenerative medicine markets, (2) expand their research pipelines, and (3)<br />receive approval of their therapies for clinical use."<br /><br />Management told me AllCells was their main competitor a while back. I'm not sure of others. <br /><br />One thing I wonder is what it would take for another blood bank to replicate what HEMA is doing. Dan Schumhttps://www.blogger.com/profile/05728696891530868697noreply@blogger.comtag:blogger.com,1999:blog-754894216207950592.post-49149897646497296692017-03-15T14:31:10.541-07:002017-03-15T14:31:10.541-07:00"They are doing everything they said they wou..."They are doing everything they said they would and why shouldn't it continue? Have they saturated the market? Is the market opportunity going to increase or decrease? They are expanding, they are signing new distribution deals, they are increasing capacity, they are doing good on communication, they are figuring out how to get their product into as many places around the world as possible."<br /><br />I think you hit the nail on the head with this commentary. If they are going to grow at anything close to 25% a year for the next 3-5 years then this is certainly not expensive, I can even see them getting taken out at $4-$5 a share based on 2016 results alone. I guess I'm trying to get some clarity on those questions. Have you found anything regarding size of market, or competitors. How big can sales grow to? I'll try to do some more research and report if I find anything helpful. Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-754894216207950592.post-14753717984015848852017-03-15T12:44:54.496-07:002017-03-15T12:44:54.496-07:00One other reason I am hesitant to sell is Fidelity...One other reason I am hesitant to sell is Fidelity won't let me buy it back. Most of my HEMA stock is with Fidelity at the momentDan Schumhttps://www.blogger.com/profile/05728696891530868697noreply@blogger.comtag:blogger.com,1999:blog-754894216207950592.post-14135866798077003442017-03-15T12:26:48.208-07:002017-03-15T12:26:48.208-07:00btw you can always email me if you want to talk mo...btw you can always email me if you want to talk more in depth. check the contact pageDan Schumhttps://www.blogger.com/profile/05728696891530868697noreply@blogger.comtag:blogger.com,1999:blog-754894216207950592.post-64525649767681436252017-03-15T12:22:18.541-07:002017-03-15T12:22:18.541-07:00Thank you
I think 2016 results were great. Sure ...Thank you<br /><br />I think 2016 results were great. Sure growth wasn't as high as last year but whatever, it was still very good. Profits are there now for the first time in year. SGA stayed about the same. Balance sheet is super clean. No debt. Now have more cash to expand. As long as revenue increases profits will increase as well. All good<br /><br />I don't know about valuation but I would say you can't separate operations from the great capital raise when thinking what the stock price should be. It would probably take a stock price of $4 for me to really think about selling, depending on the news. We may have a pullback for sure but to me all signs point to this stock going higher. They are doing everything they said they would and why shouldn't it continue? Have they saturated the market? Is the market opportunity going to increase or decrease? They are expanding, they are signing new distribution deals, they are increasing capacity, they are doing good on communication, they are figuring out how to get their product into as many places around the world as possible. <br /><br />If the stock were to spike up to $5 tomorrow I may sell some then buy on the pullback. Otherwise I'll just wait and see how it goes. I'm eager to hear what management has to say at the annual meeting. <br /><br />But I'm biased and have a cost basis of like $0.45 so you should not base your actions on my ownDan Schumhttps://www.blogger.com/profile/05728696891530868697noreply@blogger.comtag:blogger.com,1999:blog-754894216207950592.post-10431329736399472842017-03-15T12:03:29.206-07:002017-03-15T12:03:29.206-07:00Thanks, what did you think of 2016 results, and wh...Thanks, what did you think of 2016 results, and what's your take on the current valuation. Certainly nice growth rate but nowhere near the rate of previous year. There are now about 11.4m shares outstanding at $2 that's a market cap of 22.8m if we deduct cash on hand of $4.8m after the stock sale we get a EV of $18m. EBIT seem to be at $800k this gives us a EV/EBIT of 22.5 this years numbers. If we look to next year and assume 25% increase in revenue and earnings we still get an EV/EBIT of 17.5.<br /><br />Obviously EV/EBIT isn't the only way to value a business so I'm wondering what your take is on it. Thanks and congrats on a great find.Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-754894216207950592.post-79694883608528675202017-03-15T10:50:38.635-07:002017-03-15T10:50:38.635-07:00Yes that's right
On the other hand it seems O...Yes that's right<br /><br />On the other hand it seems OneBlood thinks HEMA stock is worth at least $3.44, after dilution, and presumably OneBlood knows more about HEMA than you or I. And HEMA has raised a bunch of cash without taking on any debt. <br /><br />To me this is a major win. Yes there are more shares outstanding now but look at the positives. At the time OneBlood was buying shares for $3.44 the stock was sitting at $0.65. Dan Schumhttps://www.blogger.com/profile/05728696891530868697noreply@blogger.comtag:blogger.com,1999:blog-754894216207950592.post-68062350581256168982017-03-15T10:03:53.732-07:002017-03-15T10:03:53.732-07:00From their recent report
"On January 6, 2017...From their recent report<br /><br />"On January 6, 2017, the Company entered into a Common Stock Purchase Agreement that set forth terms and conditions to offer and sell to a buyer, up to $5 million of shares of the <br />Company’s common stock, which will be offered and closed in three installments<br />at a fixed price per share. The first closing for $2.5 million occurred on January 6, 2017, with the issuance of 727,572 shares of the Company’s common stock. The second closing for $1.25 million of shares will occur, at the option of the Buyer, on or before December 31,2017, and the third closing for $1.25 million will occur, at the option of the Buyer, provided that the second closing occurred in full, on or before December 31, 2018."<br /><br />This means they've diluted shareholders to raise $5 mil right?<br />Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-754894216207950592.post-19225157594915091622017-03-02T22:05:56.676-08:002017-03-02T22:05:56.676-08:00great. I'll see you there thengreat. I'll see you there thenDan Schumhttps://www.blogger.com/profile/05728696891530868697noreply@blogger.comtag:blogger.com,1999:blog-754894216207950592.post-87125111886875082902017-03-02T15:59:59.015-08:002017-03-02T15:59:59.015-08:00I will likely make it out there, unless work stops...I will likely make it out there, unless work stops me.pakiyahttps://www.blogger.com/profile/17516457333986786704noreply@blogger.comtag:blogger.com,1999:blog-754894216207950592.post-91628425411187478592017-03-02T10:46:18.932-08:002017-03-02T10:46:18.932-08:00Yes I'll be there. And I'll post an updat...Yes I'll be there. And I'll post an update if there's anything interestingDan Schumhttps://www.blogger.com/profile/05728696891530868697noreply@blogger.comtag:blogger.com,1999:blog-754894216207950592.post-45300581886899616762017-03-02T10:39:43.348-08:002017-03-02T10:39:43.348-08:00are you planning on going to the annual meeting? are you planning on going to the annual meeting? pakiyahttps://www.blogger.com/profile/17516457333986786704noreply@blogger.comtag:blogger.com,1999:blog-754894216207950592.post-17835995435988841752017-03-02T07:02:32.742-08:002017-03-02T07:02:32.742-08:00Annual meeting will be at their headquarters in Lo...Annual meeting will be at their headquarters in Los Angeles. For dates I assume it'll be similar to last year when they released annual numbers on Apr 11 and held the annual meeting May 12. Dan Schumhttps://www.blogger.com/profile/05728696891530868697noreply@blogger.comtag:blogger.com,1999:blog-754894216207950592.post-43263036674251383692017-03-01T22:48:11.785-08:002017-03-01T22:48:11.785-08:00when and where is the annual meeting? also, how do...when and where is the annual meeting? also, how do you know the report is out in April?pakiyahttps://www.blogger.com/profile/17516457333986786704noreply@blogger.comtag:blogger.com,1999:blog-754894216207950592.post-67078241679638216192017-02-24T21:46:52.129-08:002017-02-24T21:46:52.129-08:00I have no update. Just waiting on the annual repor...I have no update. Just waiting on the annual report. Should be out in April<br /><br />The recent PRs about a distribution deal and OneBlood partnership are great. Hopefully the company will discuss those in the report or at the annual meetingDan Schumhttps://www.blogger.com/profile/05728696891530868697noreply@blogger.comtag:blogger.com,1999:blog-754894216207950592.post-11074896835811747952017-02-24T16:49:41.601-08:002017-02-24T16:49:41.601-08:00Dan,
Any update on HEMA? I've been recently b...Dan,<br /><br />Any update on HEMA? I've been recently buying up HEMA. They posted numbers for the first 6 months of 2016. The rev has increase to $5.7M. Definitely not the $20M run rate but I think they signed more distributor agreements in second half of 2016. I would think their growth rate increased in second half, but we will have to wait to see. <br />pakiyahttps://www.blogger.com/profile/17516457333986786704noreply@blogger.com